J. Alard, V. Peucelle, D. Boutillier, J. Breton, S. Kuylle et al., New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches, Benef. Microbes, vol.9, pp.317-331, 2018.

T. Allain, N. M. Mansour, M. M. Bahr, R. Martin, I. Florent et al., A new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces, FEMS Microbiol. Lett, vol.363, p.117, 2016.

P. Álvarez-martín, A. B. Flórez, A. Margolles, G. Del-solar, and B. Mayo, Improved cloning vectors for bifidobacteria, based on the bifidobacterium catenulatum pBC1 replicon, Appl. Environ. Microbiol, vol.74, pp.4656-4665, 2008.

B. Benbouziane, P. Ribelles, C. Aubry, R. Martin, P. Kharrat et al., Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces, J. Biotechnol, vol.168, pp.120-129, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01004637

L. G. Bermúdez-humarán, C. Aubry, J. Motta, C. Deraison, L. Steidler et al., Engineering lactococci and lactobacilli for human health, Curr. Opin. Microbiol, vol.16, pp.278-283, 2013.

B. Biavati and P. Mattarelli, Bifidobacterium, " in Bergey's Manual of Systematics of Archaea and Bacteria, 2015.

H. Braat, P. Rottiers, D. W. Hommes, N. Huyghebaert, E. Remaut et al., A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease, Clin. Gastroenterol. Hepatol, vol.4, pp.754-759, 2006.

N. M. Breyner, C. Michon, C. S. De-sousa, P. B. Vilas-boas, F. Chain et al., Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-?B pathway, Front. Microbiol, vol.8, p.114, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01604976

H. S. Cooper, S. N. Murthy, R. S. Shah, and D. J. Sedergran, Clinicopathologic study of dextran sulfate sodium experimental murine colitis, Lab. Invest, vol.69, pp.238-249, 1993.

M. L. Escogido, A. D. Rodríguez, and A. P. Rosa, A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum, Biotechnol. Lett, vol.29, pp.1249-1253, 2007.

C. Hill, F. Guarner, G. Reid, G. R. Gibson, D. J. Merenstein et al., Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat. Rev. Gastroenterol. Hepatol, vol.11, pp.506-514, 2014.

E. V. Khokhlova, B. A. Efimov, L. I. Kafarskaia, and A. N. Shkoporov, Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve, Arch. Microbiol, vol.192, pp.769-774, 2010.

H. Kimoto, M. Nomura, M. Kobayashi, K. Mizumachi, and T. Okamoto, Survival of lactococci during passage through mouse digestive tract, Can. J. Microbiol, vol.49, pp.707-711, 2003.

O. P. Kuipers, M. M. Beerthuyzen, P. G. De-ruyter, E. J. Luesink, and W. M. De-vos, Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction, J. Biol. Chem, vol.270, pp.27299-27304, 1995.

M. Kumar, A. Kumar-yadav, V. Verma, B. Singh, G. Mal et al., Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects, Future Microbiol, vol.11, pp.585-600, 2016.

S. A. Limaye, R. I. Haddad, F. Cilli, S. T. Sonis, A. D. Colevas et al., Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy, Cancer, vol.119, pp.4268-4276, 2013.

L. Losurdo, L. Quintieri, L. Caputo, R. Gallerani, B. Mayo et al., Cloning and expression of synthetic genes encoding angiotensin-I converting enzyme (ACE)-inhibitory bioactive peptides in Bifidobacterium pseudocatenulatum, FEMS Microbiol. Lett, vol.340, pp.24-32, 2013.

R. Martín, R. Martín, F. Chain, F. Chain, S. Miquel et al., Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation, Hum. Vaccines Immunother, vol.10, pp.1611-1621, 2014.

O. Ménard, M. Butel, V. Gaboriau-routhiau, and A. Waligora-dupriet, Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants, Appl. Environ. Microbiol, vol.74, pp.660-666, 2008.

E. Morello, L. G. Bermúdez-humarán, D. Llull, V. Solé, N. Miraglio et al., Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion, J. Mol. Microbiol. Biotechnol, vol.14, pp.48-58, 2008.

J. Motta, L. G. Bermúdez-humarán, C. Deraison, L. Martin, C. Rolland et al., Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis, Sci. Transl. Med, vol.4, pp.158-144, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01204261

C. Moubareck, F. Gavini, L. Vaugien, M. J. Butel, and F. Doucet-populaire, Antimicrobial susceptibility of bifidobacteria, J. Antimicrob. Chemother, vol.55, pp.38-44, 2005.

S. Pavan, P. Desreumaux, and A. Mercenier, Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria, Clin. Diagn. Lab. Immunol, vol.10, pp.696-701, 2003.

J. Preising, D. Philippe, M. Gleinser, H. Wei, S. Blum et al., Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis, Appl. Environ. Microbiol, vol.76, pp.3048-3051, 2010.

J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning: a Laboratory Manual, 1989.

B. Sánchez, M. Champomier-vergès, P. Anglade, F. Baraige, C. G. De-los-reyes-gavilán et al., Proteomic analysis of global changes in protein expression during bile salt exposure of Bifidobacterium longum NCIMB 8809, J. Bacteriol, vol.187, pp.5799-5808, 2005.

M. A. Schell, M. Karmirantzou, B. Snel, D. Vilanova, B. Berger et al., The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract, Proc. Natl. Acad. Sci. U.S.A, vol.99, pp.14422-14427, 2002.

V. M. Sheehan, R. D. Sleator, C. Hill, and G. F. Fitzgerald, Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003, Microbiology, vol.153, pp.3563-3571, 2007.

T. Shirakawa and K. Kitagawa, Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine, Hum. Vaccines Immunother, vol.0, pp.1-4, 2017.

R. Syto, N. J. Murgolo, E. H. Braswell, P. Mui, E. Huang et al., Structural and biological stability of the human interleukin 10 homodimer, Biochemistry, vol.37, pp.16943-16951, 1998.

S. Takei, C. Omoto, K. Kitagawa, N. Morishita, T. Katayama et al., Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice, Vaccine, vol.32, pp.3066-3074, 2014.

J. L. Wallace and C. M. Keenan, An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis, Am. J. Physiol. Gastrointest. Liver Physiol, vol.258, pp.527-534, 1990.

Z. Yu, Z. Huang, C. Sao, Y. Huang, F. Zhang et al., Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71, Arch. Virol, vol.158, pp.1071-1077, 2013.

Q. Zhang, M. Liu, S. Li, Z. Xu, J. Wang et al., Oral Bifidobacterium longum expressing GLP-2 improves nutrient assimilation and nutritional homeostasis in mice, J. Microbiol. Methods, vol.145, pp.87-92, 2018.